Inventor · disambiguated record
Katherine E. Lewis
Also filed as: LEWIS KATHERINE · LEWIS KATHERINE E
19 granted patents·22 pending applications·272 citations·filing 2003–2025
95Inventor score
Files withBRISTOL MYERS SQUIBB CO13ZYMOGENETICS INC10FIVE PRIME THERAPEUTICS INC7LEWIS KATHERINE E5LEVIN STEVEN D3
Top patents by PatentIndex Score
41 records- 0197US7910703B2Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of useZYMOGENETICS INC·Filed 2008·Granted Mar 22, 2011·46 cites·14 claims
- 0296US11274152B2Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Mar 15, 2022·6 cites·12 claims
- 0396US7790862B2IL-17 and IL-23 antagonists and methods of using the sameZYMOGENETICS INC·Filed 2007·Granted Sep 7, 2010·49 cites·14 claims
- 0495US9765147B2Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancerFIVE PRIME THERAPEUTICS INC·Filed 2015·Granted Sep 19, 2017·25 cites·31 claims
- 0595US8333968B2Methods of inhibiting inflammation with antagonists to IL-17A, IL-17F, and IL-23P19LEWIS KATHERINE E·Filed 2011·Granted Dec 18, 2012·30 cites·14 claims
- 0693US10081681B2Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Sep 25, 2018·17 cites·18 claims
- 0793US8496936B2Antagonists of IL-17A, IL-17F, and IL-23P19LEWIS KATHERINE E·Filed 2012·Granted Jul 30, 2013·19 cites·2 claims
- 0892US10221244B2Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancerFIVE PRIME THERAPEUTICS INC·Filed 2017·Granted Mar 5, 2019·10 cites·31 claims
- 0988US10618967B2Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancerFIVE PRIME THERAPEUTICS INC·Filed 2019·Granted Apr 14, 2020·5 cites·31 claims
- 1088US8992922B2Antagonists of IL-17A, IL-17F, and IL-23P19ZYMOGENETICS INC·Filed 2013·Granted Mar 31, 2015·7 cites·3 claims
- 1188US7291589B2Uses of human Zven proteins and polynucleotidesZYMOGENETICS INC·Filed 2003·Granted Nov 6, 2007·20 cites·21 claims
- 1287US8822642B2Dimeric fusion proteins and related compositions and methodsLEVIN STEVEN D·Filed 2011·Granted Sep 2, 2014·27 cites·15 claims
- 1383US8227579B2IL-23 antagonistsLEWIS KATHERINE E·Filed 2010·Granted Jul 24, 2012·8 cites·5 claims
- 1482US9464134B2Polynucleotides encoding antagonists of IL-17A, IL-17F, and IL-23p19ZYMOGENETICS INC·Filed 2015·Granted Oct 11, 2016·2 cites·5 claims
- 1581US2023212299A1Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for CancerFIVE PRIME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1681US2024150459A1Anti-LAG-3 Antibodies to Treat Hematological MalignanciesBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1778US9994634B2Use of an IL-17/IL-23 bispecific antibody for treating inflammationZYMOGENETICS INC·Filed 2016·Granted Jun 12, 2018·1 cites·4 claims
- 1877US2022185892A1Combination of Anti-LAG-3 Antibodies and Anti-PD-1 Antibodies to Treat TumorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1974US2025163155A1Combination of anti-lag-3 antibodies and anti-pd-1 antibodies to treat tumorsBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 2071US11566076B2Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected cancersFIVE PRIME THERAPEUTICS INC·Filed 2020·Granted Jan 31, 2023·0 cites·25 claims
- 2171US2025197495A1Anti-lag-3 antibodies to treat hematological malignanciesBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 2269US2009312258A1Uses of human zven proteins and polynucleotidesLEWIS KATHERINE E·Filed 2009·Application pending·0 cites
- 2369US2021122820A1Anti-LAG-3 Antibodies to Treat Hematological MalignanciesBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2468US10562967B2Treating inflammation with IL-17/IL-23 bispecific antibodiesZYMOGENETICS INC·Filed 2018·Granted Feb 18, 2020·0 cites·4 claims
- 2566US2022127363A1Use of anti-ctla-4 antibodies with enhanced adcc to enhance immune response to a vaccineBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2665US2023192870A1Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pancreatic CancerFIVE PRIME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2764US7592312B2Methods of modulating gastrointestinal contractilityZYMOGENETICS INC·Filed 2006·Granted Sep 22, 2009·0 cites·30 claims
- 2864US2020062845A1Combination of anti-lag-3 antibodies and anti-pd-1 antibodies to treat tumorsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 2959US11421034B2Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancerFIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Aug 23, 2022·0 cites·15 claims
- 3059US2018244773A1Anti-lag-3 antibodies to treat hematological malignanciesBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 3155US2007249533A1Il-17a and il-17f antagonists and methods of using the sameLEVIN STEVEN D·Filed 2007·Application pending·0 cites
- 3255US2007049524A1Soluble zcytor21, anti-zcytor21 antibodies and binding partners and methods of using in inflammationZYMOGENETICS INC·Filed 2006·Application pending·0 cites
- 3355US2007049525A1Soluble zcytor21, anti-zcytor21 antibodies and binding partners and methods of using in inflammationZYMOGENETICS INC·Filed 2006·Application pending·0 cites
- 3453US2007014736A1Methods of delivering corticotroph-derived glycoprotein hormoneOKADA SHANNON L·Filed 2006·Application pending·0 cites
- 3552US2006142192A1Soluble ZcytoR21, anti-ZcytoR21 antibodies and binding partners and methods of using in inflammationGAO ZEREN·Filed 2005·Application pending·0 cites
- 3652US2019382490A1Use of anti-ctla-4 antibodies with enhanced adcc to enhance immune response to a vaccineBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 3750US2012295310A1Nucleic acids encoding anti-il-23 antibodiesLEWIS KATHERINE E·Filed 2012·Application pending·0 cites
- 3850US2016326248A1Anti-lag-3 antibodies to treat hematological malignanciesBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 3945US2007238658A1IL-17A and IL-17F Antagonists and Methods of Using the SameLEVIN STEVEN D·Filed 2006·Application pending·0 cites
- 4044US2018214547A1Treatment of cancer using a combination of an anti-pd-1 antibody and il-6BRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 4144US2007129302A1Il-17c antagonists and methods of using the sameGAO ZEREN·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →